Antimicrobial Stewardship and Policy

Antimicrobial Stewardship and Policy

Project 19 May 2021
119

Robust antimicrobial stewardship policy is an integral part of any management and mitigation strategy of AMR.

We contribute to policy studies within the antimicrobial stewardship and antimicrobial R&D space in an effort to conserve the efficacy of the antimicrobials we currently have, whilst at the same time extend the time available to find urgently needed new antimicrobials.

We contribute to policy studies within the antimicrobial stewardship and antimicrobial R&D space in an effort to conserve the efficacy of the antimicrobials we currently have, whilst at the same time extend the time available to find urgently needed new antimicrobials.

Recent articles

Rodríguez-Baño J, et al. Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2021. https://doi.org/10.1093/trstmh/trab048

Kirchhelle C, et al. Setting the standard: multidisciplinary hallmarks for structural, equitable and tracked antibiotic policy. BMJ Global Health. 2020. http://dx.doi.org/10.1136/bmjgh-2020-003091

Ghebrehewet S, et al. Implementation of a Delayed Prescribing Model to Reduce Antibiotic Prescribing for Suspected Upper Respiratory Tract Infections in a Hospital Outpatient Department, Ghana. Antibiotics (Basel). 2020. https://doi.org/10.3390/antibiotics9110773

Singer AC, et al. (Inter)nationalising the antibiotic research and development pipeline. Lancet Infectious Diseases. 2020 https://doi.org/10.1016/S1473-3099(19)30552-3